We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Caspian Sunrise Plc | LSE:CASP | London | Ordinary Share | GB00B1W0VW36 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.35 | 3.30 | 3.40 | 3.35 | 3.35 | 3.35 | 824,036 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Oil And Gas Field Expl Svcs | 42.95M | 9.76M | 0.0043 | 7.79 | 75.39M |
TIDMRXP
RNS Number : 1295J
Roxi Petroleum Plc
01 April 2015
Roxi Petroleum PLC
("Roxi" or the "Company")
Directors dealings in the Company's shares
In January 2014, Roxi agreed a $40 million equity facility with Kairat Satylganov with the shares to be issued at an agreed price of 7.41p per share. To date some $29.2 million has been called under the facility and 244,670,973 shares representing 27.68 per cent of Roxi have been issued.
The Company announces that on 1 April 2015, Kuat Oraziman, CEO and a director of the Company acquired 39,242,317 Roxi shares (the "Sale Shares") representing 4.44 per cent of the current issued share capital from Kairat Satylganov, CFO and a director of the Company, at a price of 7.41p.
Following this sale Kuat Oraziman has an interest in 374,408,033 shares representing 42.35 per cent and the Kairat Satylganov has an interest in 205,428,656 shares representing 23.24 per cent of Roxi.
Enquiries:
Roxi Petroleum PLC Clive Carver, Chairman
+7 727 375 0202
WH Ireland Ltd James Joyce / James Bavister
+44 (0) 207 220 1666
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSLIFSDSEILIIE
1 Year Caspian Sunrise Chart |
1 Month Caspian Sunrise Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions